Partnering with

MOGRIFY

Mogrify is looking to partner with disruptive innovators in the fields of regenerative medicine, ex vivo cell therapy and in vivo reprogramming therapy to develop treatments for indications of high unmet clinical need. We are particularly interested in speaking with those with interest in immuno-oncology, ophthalmology as well as other disease areas where these modalities may be of interest. Mogrify is commercializing its technology via a combination of internal therapy development, co-development partnerships, and out-licensing of novel cell conversions applicable to non-core markets.

Current

PARTNERS

Sangamo Therapeutics

Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering.

Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells

MRC Laboratory of Molecular Biology

MRC Laboratory for Molecular Biology

The MRC Laboratory of Molecular Biology (LMB) is a research institute dedicated to the understanding of important biological processes at the levels of atoms, molecules, cells and organisms. In doing so, they provide knowledge needed to solve key problems in human health.

Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology

Duke-NUS Medical School

Duke-NUS Medical School

Duke-NUS Medical School is a research powerhouse and our distinguished scientists are transforming the way we understand, diagnose and treat diseases. Our founder, Assistant Professor, Owen Rackham, and his group at the School focus on what defines human cells and how their phenotype emerges from the complex interplay between the genome, transcriptome and environment. Developing methods that leverage the large volume of gene expression, epigenetic and interaction data that is being generated to develop biological hypotheses about how certain perturbations can influence cell fate.

Monash University

Monash University

The Polo Laboratory, a part of the Monash Biomedicine Discovery Institute at Monash University, focuses on the transcriptional and epigenetic mechanisms that govern cell identity, in particular, pluripotency and the reprogramming of somatic cells into induced pluripotent stem (iPS) cells.

Our

PIPELINE

AREA Sample Acquisition Bioinformatics In vitro PoC In vivo PoC IND Clinical Marketing
Immunotherapy
(Oncology)
mogrify mogrify mogrify mogrify   partner partner
Ophthalmology
(Retinal)
mogrify mogrify mogrify     partner partner
Collaborations
(Pulmonary, Metabolic & Others)
mogrify mogrify mogrify partner partner partner partner
               
    mogrify Mogrify Progress partner Expect to Partner    

Upcoming

Events & Conferences

2 May
-
6 May 2021
Region:
Virtual Conference(s)
Attendee:
Dr. Geraint Parfitt, Principal Scientist, Mogrify and Robert Cann, Strategy & BD Manager, Mogrify
Presentation title:
Presentation date:
Booth:

The theme of the 2021 ARVO Annual Meeting is the next revolution of clinically translating these discoveries to restore and preserve vision.

11 May
-
14 May 2021
Region:
Virtual Conference(s)
Attendee:
Dr. David Matthews, Director of R&D, Mogrify and Dr. Raul Elgueta Rebolledo, Principal Scientist, Mogrify
Presentation title:
Presentation date:
Booth:

We are exhibiting at the ASGCT 2021. Join us for the field’s premier event, and take in the cutting edge science with leaders from academia, medicine, industry, advocacy, and more.

18 May
-
19 May 2021
Region:
Virtual Conference(s)
Speaker:
Sponsored by Mogrify
Presentation title:
Translating Cellular Reprogramming into Efficacious and Scalable Cell Therapies for Immuno-Oncology
Presentation date:
Booth:

The first ELRIG meeting on Advances in Cell and Gene Therapies will be held on the 18th and 19th of May 2021 virtually. This interactive 2-day conference will host world-leading scientists from academia and industry to discuss current and future perspectives of Cell and Gene Therapies.

19 May
-
21 May 2021
Region:
Virtual Conference(s)
Attendee:
Tim Landy, Director of Corporate Development, Mogrify
Presentation title:
Presentation date:
Booth:

Advanced Therapies 2021 brings together the life science community to meet, do business and solve the challenges preventing ATMPs from getting to market and saving patient lives.

7 June
-
10 June 2021
Region:
Virtual Conference(s)
Attendee:
Dr, Alessadra De Riva, Director of Development, Mogrify
Presentation title:
Presentation date:
Booth:

The CASSS Cell and Gene Therapy Products symposium enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products.

9 June
-
10 June 2021
Region:
Virtual Conference(s)
Speaker:
Dr. Darrin Disley, CEO, Mogrify
Presentation title:
Presentation date:
Booth:

The British Pharmacology Society and the Society for Medicines Research are pleased to announce their 2021 joint meeting, specifically targeted towards all early-career researchers and scientists from across the World with an interest in drug discovery.

14 June
-
17 June 2021
Region:
Virtual Conference(s)
Attendee:
Pierre Louis Joffrin, Corporate Development Executive, Mogrify
Presentation title:
Presentation date:
Booth:

Join the BIO International Convention 2021 to find innovative collaborations and partnerships.

23 June
-
26 June 2021
Region:
Virtual Conference(s)
Attendee:
Dr. Rodrigo Santos, Director of Cell Technologies, Mogrify
Presentation title:
Presentation date:
Booth:

The ISSCR Annual Meeting gathers the world’s leading scientists, clinicians, business leaders, ethicists, and educators from more than 65 countries. Together, we represent the full spectrum of stem cell science and regenerative medicine. Discovery, new business, careers, advocacy, and relationships start here.

8 September
-
10 September 2021
Region:
Europe
Host:
Sponsored by Mogrify
Presentation title:
Presentation date:
Booth:

We are proud to be sponsoring the Cambridge International Stem Cell Symposium in September 2021.